🔗 Share this article

Treasury head Reeves has revealed she is preparing "focused measures to address household expense issues" in the upcoming financial statement.

During an interview with media outlets, she emphasized that reducing inflation is a joint task of both the administration and the Bank of England.

The UK's price growth is forecast to be the highest among the G7 advanced economies this calendar year and the following year.

Possible Utility Cost Interventions

Reports indicate the administration could intervene to bring down energy bills, for instance by cutting the present 5% rate of value-added tax applied on energy.

Another approach is to cut some of the regulatory levies currently included in bills.

Budgetary Limitations and Expert Predictions

The government will obtain the next report from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much space there is for such measures.

The consensus from most economists is that the Chancellor will have to introduce tax rises or budget cuts in order to adhere to her voluntary debt limits.

Previously on the same day, estimates showed there was a twenty-two billion pound shortfall for the Treasury chief to fill, which is at the more modest range of expectations.

"There's a joint responsibility between the central bank and the administration to continue tackling some of the causes of price increases," Reeves told reporters in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Revenue Commitments and Global Issues

While much of the focus has been on probable tax increases, the Treasury chief said the latest data from the OBR had not altered her vow to election pledges not to raise tax levels on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable world" with rising international and trade tensions for the Budget revenue measures, probably to be directed on those "wealthiest."

Global Trade Tensions

Addressing apprehensions about the UK's commercial links with the Asian nation she said: "Our national security invariably take priority."

Recent announcement by China to strengthen trade restrictions on critical minerals and other resources that are essential for high-technology production led US President Donald Trump to suggest an further 100% import tax on goods from the Asian country, raising the risk of an full-scale trade war between the two largest economies.

The US Treasury Secretary labeled the Chinese action "commercial pressure" and "a international production control attempt."

Inquired about accepting the American proposal to join its battle with the Asian nation, Reeves said she was "very concerned" by China's measures and called on the Chinese government "not to put up barriers and restrict access."

She said the decision was "bad for the world economy and causes further challenges."

"In my view there are areas where we must challenge China, but there are also significant prospects to sell into Chinese markets, including financial services and other areas of the economy. We've got to maintain that equilibrium appropriate."

The Treasury chief also affirmed she was working with other major economies "regarding our own essential resources strategy, so that we are less reliant."

Health Service Drug Pricing and Funding

The Chancellor also admitted that the cost the National Health Service spends on drugs could go up as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in return for reduced taxes and capital.

A number of the world's largest pharmaceutical manufacturers have said in recent statements that they are either pausing or scrapping investments in the UK, with several attributing the modest returns they are obtaining.

Last month, the Science Minister said the cost the health service spends on drugs would have to rise to stop businesses and pharmaceutical investment leaving the United Kingdom.

The Chancellor informed the BBC: "We have seen because of the pricing regime, that drug testing, innovative medicines have not been available in the UK in the manner that they are in other EU nations."

"The objective is to ensure that individuals getting care from the NHS are able to access the top essential drugs in the world. And so we are examining all of that, and... looking to secure additional capital into Britain."